Acadia Healthcare (NASDAQ:ACHC) Reaches New 52-Week Low – Here’s Why

Acadia Healthcare Company, Inc. (NASDAQ:ACHC)’s share price hit a new 52-week low on Wednesday . The company traded as low as $28.04 and last traded at $28.12, with a volume of 60054 shares. The stock had previously closed at $29.12.

Analyst Ratings Changes

Several research analysts have commented on the company. StockNews.com lowered Acadia Healthcare from a “hold” rating to a “sell” rating in a research report on Monday, January 6th. Bank of America dropped their target price on Acadia Healthcare from $50.00 to $44.50 and set a “buy” rating on the stock in a report on Friday, February 28th. Barclays downgraded shares of Acadia Healthcare from an “overweight” rating to an “equal weight” rating and lowered their price objective for the company from $43.00 to $35.00 in a research report on Friday, February 28th. KeyCorp reduced their target price on shares of Acadia Healthcare from $70.00 to $65.00 and set an “overweight” rating on the stock in a research report on Monday, March 3rd. Finally, Deutsche Bank Aktiengesellschaft raised shares of Acadia Healthcare from a “hold” rating to a “buy” rating and raised their price target for the company from $45.00 to $75.00 in a report on Thursday, December 12th. One investment analyst has rated the stock with a sell rating, three have assigned a hold rating and five have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $56.31.

Acadia Healthcare Stock Down 4.7 %

The stock has a market capitalization of $2.58 billion, a price-to-earnings ratio of 9.11, a PEG ratio of 1.46 and a beta of 1.38. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.07 and a quick ratio of 1.07. The firm’s fifty day moving average is $40.93 and its 200-day moving average is $49.36.

Hedge Funds Weigh In On Acadia Healthcare

A number of hedge funds have recently bought and sold shares of the company. Wellington Management Group LLP lifted its holdings in Acadia Healthcare by 0.7% during the 4th quarter. Wellington Management Group LLP now owns 11,734,743 shares of the company’s stock worth $465,283,000 after buying an additional 76,490 shares during the last quarter. FMR LLC raised its position in shares of Acadia Healthcare by 257.9% during the 4th quarter. FMR LLC now owns 6,230,631 shares of the company’s stock valued at $247,045,000 after acquiring an additional 4,489,681 shares in the last quarter. Dimensional Fund Advisors LP lifted its stake in Acadia Healthcare by 18.0% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,182,729 shares of the company’s stock worth $126,189,000 after purchasing an additional 486,395 shares during the last quarter. JPMorgan Chase & Co. boosted its holdings in Acadia Healthcare by 17.0% in the third quarter. JPMorgan Chase & Co. now owns 3,126,607 shares of the company’s stock worth $198,258,000 after purchasing an additional 454,044 shares during the period. Finally, State Street Corp increased its stake in Acadia Healthcare by 3.5% during the third quarter. State Street Corp now owns 2,819,911 shares of the company’s stock valued at $178,811,000 after purchasing an additional 95,613 shares during the last quarter.

About Acadia Healthcare

Acadia Healthcare Company, Inc provides behavioral healthcare services in the United States and Puerto Rico. The company develops and operates acute inpatient psychiatric facilities, specialty treatment facilities comprising residential recovery facilities and eating disorder facilities, comprehensive treatment centers, and residential treatment centers, as well as facilities offering outpatient behavioral healthcare services for the behavioral healthcare and recovery needs of communities.